COLUMBIA/HCA, HEALTHTRUST MERGER WILL CREATE $15 BIL. PROVIDER
This article was originally published in The Gray Sheet
COLUMBIA/HCA, HEALTHTRUST MERGER WILL CREATE $15 BIL. PROVIDER of health care, owning and operating 311 hospitals with 60,000 beds and 125 outpatient centers. Under a definitive agreement announced Oct. 4, HealthTrust shareholders would receive 0.88 shares of Columbia stock for each HealthTrust share in what the companies plan to be a tax-free pooling of interests. The deal is valued at $5.4 bil.; the HealthTrust stock is worth $3.6 bil., and Columbia/HCA will assume $1.8 bil. in HealthTrust debt.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.